» Articles » PMID: 34451903

Pharmaceutical Drugs and Natural Therapeutic Products for the Treatment of Type 2 Diabetes Mellitus

Overview
Publisher MDPI
Specialty Chemistry
Date 2021 Aug 28
PMID 34451903
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

Type 2 diabetes mellitus (T2DM) is the most widespread form of diabetes, characterized by chronic hyperglycaemia, insulin resistance, and inefficient insulin secretion and action. Primary care in T2DM is pharmacological, using drugs of several groups that include insulin sensitisers (e.g., biguanides, thiazolidinediones), insulin secretagogues (e.g., sulphonylureas, meglinides), alpha-glucosidase inhibitors, and the newest incretin-based therapies and sodium-glucose co-transporter 2 inhibitors. However, their long-term application can cause many harmful side effects, emphasising the importance of the using natural therapeutic products. Natural health substances including non-flavonoid polyphenols (e.g., resveratrol, curcumin, tannins, and lignans), flavonoids (e.g., anthocyanins, epigallocatechin gallate, quercetin, naringin, rutin, and kaempferol), plant fruits, vegetables and other products (e.g., garlic, green tea, blackcurrant, rowanberry, bilberry, strawberry, cornelian cherry, olive oil, sesame oil, and carrot) may be a safer alternative to primary pharmacological therapy. They are recommended as food supplements to prevent and/or ameliorate T2DM-related complications. In the advanced stage of T2DM, the combination therapy of synthetic agents and natural compounds with synergistic interactions makes the treatment more efficient. In this review, both pharmaceutical drugs and selected natural products, as well as combination therapies, are characterized. Mechanisms of their action and possible negative side effects are also provided.

Citing Articles

Unlocking the multifaceted roles of GLP-1: Physiological functions and therapeutic potential.

Al-Noshokaty T, Abdelhamid R, Abdelmaksoud N, Khaled A, Hossam M, Ahmed R Toxicol Rep. 2025; 14:101895.

PMID: 39911322 PMC: 11795145. DOI: 10.1016/j.toxrep.2025.101895.


Optimization of the extraction methods and evaluation of the hypoglycemic effect of extracts on artificially induced diabetic mice.

Ahmed M, Raby K, Tasnim N, Islam M, Chowdhury M, Juthi Z Heliyon. 2025; 11(1):e41627.

PMID: 39866458 PMC: 11758211. DOI: 10.1016/j.heliyon.2025.e41627.


Protective Role of Dietary Polyphenols in the Management and Treatment of Type 2 Diabetes Mellitus.

Martiniakova M, Sarocka A, Penzes N, Biro R, Kovacova V, Mondockova V Nutrients. 2025; 17(2).

PMID: 39861406 PMC: 11767469. DOI: 10.3390/nu17020275.


The General Principle of the Warburg Effect as a Possible Approach for Cancer Immunotherapy: The Regulatory Effect of Plant Extracts Could Change the Game.

Ivanova D, Semkova S, Grigorov B, Tzanova M, Georgieva A, Danchev D Molecules. 2025; 30(2).

PMID: 39860262 PMC: 11767411. DOI: 10.3390/molecules30020393.


The Effects of Glucagon-Like Peptide-1 Receptor Agonists on Mitochondrial Function Within Skeletal Muscle: A Systematic Review.

Old V, Davies M, Papamargaritis D, Choudhary P, Watson E J Cachexia Sarcopenia Muscle. 2025; 16(1):e13677.

PMID: 39815782 PMC: 11735953. DOI: 10.1002/jcsm.13677.


References
1.
Zhang D, Fu M, Gao S, Liu J . Curcumin and diabetes: a systematic review. Evid Based Complement Alternat Med. 2013; 2013:636053. PMC: 3857752. DOI: 10.1155/2013/636053. View

2.
Shi G, Li Y, Cao Q, Wu H, Tang X, Gao X . In vitro and in vivo evidence that quercetin protects against diabetes and its complications: A systematic review of the literature. Biomed Pharmacother. 2018; 109:1085-1099. DOI: 10.1016/j.biopha.2018.10.130. View

3.
Rendell M . The role of sulphonylureas in the management of type 2 diabetes mellitus. Drugs. 2004; 64(12):1339-58. DOI: 10.2165/00003495-200464120-00006. View

4.
Hutchins A, Brown B, Cunnane S, Domitrovich S, Adams E, Bobowiec C . Daily flaxseed consumption improves glycemic control in obese men and women with pre-diabetes: a randomized study. Nutr Res. 2013; 33(5):367-75. DOI: 10.1016/j.nutres.2013.02.012. View

5.
Ghodsi M, Larijani B, Keshtkar A, Nasli-Esfahani E, Alatab S, Mohajeri-Tehrani M . Mechanisms involved in altered bone metabolism in diabetes: a narrative review. J Diabetes Metab Disord. 2016; 15:52. PMC: 5111345. DOI: 10.1186/s40200-016-0275-1. View